In a study by Shi and colleagues [43], increased PD-1 expression in circulating and tumor-infiltrating CD8+ T cells were associated with poor disease progression, such as shorter disease-free survival in HCC. The gene discussed is CD8A; the disease is hepatocellular carcinoma.